Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Accured Expenses (2016 - 2025)

Marimed (MRMD) has disclosed Change in Accured Expenses for 15 consecutive years, with $259000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 125.1% to $259000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, up 80.27% year-over-year, with the annual reading at $3.2 million for FY2025, 80.27% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $259000.0 at Marimed, down from $1.3 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $5.1 million in Q2 2021, with the low at -$8.8 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is $93100.0, with a median of -$132500.0 recorded in 2021.
  • Peak annual rise in Change in Accured Expenses hit 3223.55% in 2021, while the deepest fall reached 742.35% in 2021.
  • Over 5 years, Change in Accured Expenses stood at -$8.8 million in 2021, then soared by 96.72% to -$289000.0 in 2022, then crashed by 491.0% to -$1.7 million in 2023, then soared by 39.58% to -$1.0 million in 2024, then soared by 125.1% to $259000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $259000.0, $1.3 million, and -$281000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.